Patents Assigned to TRIOAR, INC.
  • Patent number: 12576156
    Abstract: The present invention provides a compound comprising a self-immolative group and a ligand-drug conjugate comprising the same. According to the present invention, an active substance can be stably delivered to a target site, and the active substance can be rapidly released at the target site, thereby increasing the efficacy of the active substance, and the active substance can be inhibited from causing side effects at a location other than the target location.
    Type: Grant
    Filed: November 22, 2024
    Date of Patent: March 17, 2026
    Assignee: TRIOAR, INC.
    Inventors: Sung Ho Woo, Su Ho Park, Jong Un Cho, Sang Hyeon Yun, Gyoung Wook Min, Ok Ku Park, Hyun Mi Lee